Treatment of severe cutaneous lupus erythematosuswith a chimeric CD4 monoclonal antibody, cM-T412
- 29 February 1996
- journal article
- case report
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 34 (2) , 244-252
- https://doi.org/10.1016/s0190-9622(96)80119-8
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Chimeric cd4 monoclonal antibody cm‐t412 as a therapeutic approach to rheumatoid arthritisArthritis & Rheumatism, 1993
- From Antilymphocyte Serum to Therapeutic Monoclonal Antibodies: First Experiences with a Chimeric CD4 Antibody in the Treatment of Autoimmune DiseaseImmunological Reviews, 1992
- Treatment of rheumatoid arthritis with monoclonal CD4 antibody M‐T151. Clinical results and immunopharmacologic effects in an open study, including repeated administrationArthritis & Rheumatism, 1991
- Treatment of rheumatoid arthritis with an anti‐CD4 monoclonal antibodyArthritis & Rheumatism, 1991
- Comparison of serum and synovial fluid concentrations of beta 2-microglobulin and C reactive protein in relation to clinical disease activity and synovial inflammation in rheumatoid arthritis.Annals of the Rheumatic Diseases, 1989
- Serum β2-Microglobulin as a Marker of Activity in Systemic Lupus ErythematosusScandinavian Journal of Rheumatology, 1986
- Serum β2-microglobulin in systemic sclerosisClinical Rheumatology, 1985
- Therapy with monoclonal antibodies by elimination of T-cell subsets in vivoNature, 1984
- Biochemistry of major human histocompatibility antigensImmunology Today, 1980
- Follow Up of Patients with Chronic Discoid Lupus ErythematosusDermatology, 1963